期刊文献+

姜黄素类铂(Ⅱ)配合物的合成及其抗肿瘤活性 被引量:3

Synthesis and Antitumor Activities of Platinum(Ⅱ) Complexes of Curcumin Analog
原文传递
导出
摘要 以乙醇为溶剂,用自制的姜黄素衍生物(L1~L4)和碘亚铂酸钾为原料,合成得到了4种姜黄素类铂(II)配合物(A~D),通过FT-IR、1H NMR、MS、差热热重和元素分析对所有目标化合物进行了结构表征.应用MTT(3-(4,5-二甲基噻唑-2)-2,5-二苯基四氮唑溴盐)法研究了化合物体外对人肺腺癌A549、子宫颈癌HeLa和乳腺癌MCF-7细胞的抗肿瘤活性,结果表明这些化合物对上述癌细胞均有较强活性;并用抑瘤率测定了人肺腺瘤(A549)细胞的抑制作用,体内试验也显示铂(II)配合物A具有抗人肺腺癌瘤(A549)作用.其中剂量为800 mg·kg-1的抗瘤活性与顺铂相当,它的半数致死量为945.6 mg·kg-1. Four kinds of platinum(Ⅱ) complexes of curcumin analog(A~D) were synthesized by self-made curcumin derivatives(L1~L4) and potassium tetraiodoplatinate(Ⅱ) as the starting material with ethanol as solvent.Their compositions were characterized by FT-IR,1H NMR,MS,TG-DTA and elemental analysis.MTT(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was used to study the com-plexes' antitumor activity in vitro against human lung adenocarcinoma cancer cell line(A549),human cervix cancer cell line(Hela) and human breast cancer cell line(MCF-7),the results showed that the complexes had strong antitumor activity against these cell lines.Inhibition of human liver tumor of A549 was examined by antitumor rate,complex A showed inhibition activity on transplanting-tumor growth of A549,800 mgo kg-1 was as potent as cisplatin,its LD50 was 945.6 mgokg-1.
出处 《化学学报》 SCIE CAS CSCD 北大核心 2011年第19期2335-2340,共6页 Acta Chimica Sinica
基金 国家自然科学基金(No.21071001) 安徽省级高校自然科学研究重点项目(No.KJ2010A222) 现代中药安徽省工程技术研究中心项目 安徽中医学院自然科学研究重点项目(No.2011zr005A)
关键词 姜黄素 铂(Ⅱ)配合物 合成 抗肿瘤活性 curcumin platinum(Ⅱ) complex synthesis antitumor activity
  • 相关文献

参考文献19

  • 1Ernest, W.; Chhristen, M. G. Chem. Rev. 1999, 99, 2451.
  • 2Cleare, M. J.; Hoeschele, J. D. Platinum Met. Rev. 1973, 17(1), 2.
  • 3Kellend, L. R.; Sharp, S. Y.; Oneill, C. F. J. Inorg. Biochem. 1999, 77, 111.
  • 4Levari, S.; Starr, A.; Vexler, A.; Karaush, V.; Loew, V.; Greif, J.; Fenig, E.; Aderra, D. Anticancer Res. 2006, 26(6B), 4423.
  • 5Su, C.-C.; Lin, J. G.; Li, T.-M.; Chung, J.-G.; Yang, J.-S.; Ip, S.-W.; Lin, W.-C.; Chert, G.-W. Anticancer Res. 2006, 26(6B), 4379.
  • 6Mishra, S.; Narain, U.; Mishra, R.; Misra, K. Bioorg. Med. Chem. 2005, 13(5), 1477.
  • 7Junko, I.; Ohtsu, H.; Yoko, T.; Tachibana, Y.; Nakanishi, Y.; Bastow, K. F.; Nagi, M.; Wang, H.-K.; Itokowa, H.; Lee, K.-H. Bioorg. Med. Chem. 2002, 10, 3481.
  • 8John, V. D.; Kuttan, G.; Krishnankutty, K. J. Exp. Clin. Cancer Res. 2002, 21(2), 219.
  • 9Song, Y.-M.; Xu, J.-D.; Ding, L.-J.; Hou, Q.; Liu, J.-W.; Zhu, Z.-L. J. Inorg. Biochem. 2009, 103(3), 396.
  • 10张金超,龚钰秋,郑小明,崔景荣,杨梦甦.碘桥双核铂配合物的合成及其抗肿瘤活性[J].科学通报,2006,51(7):796-801. 被引量:6

二级参考文献23

共引文献9

同被引文献26

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部